Literature DB >> 27059499

The Effects of IL-22 on the Inflammatory Mediator Production, Proliferation, and Barrier Function of HUVECs.

Xian He1, Hui Li1, Ying Chen1, Aijun Chen1, Kui Shan1, Jin Chen1, Hengguang Zhao1, Xiaojiao Zhang1, Tao Cai2.   

Abstract

The aim of this study was to investigate the effects of interleukin (IL)-22 on proliferation function and inflammatory mediator production and barrier function of human umbilical vein endothelial cells (HUVECs). The expression of mRNA was detected by RT-PCR. The proliferation ability of cells was evaluated using a cell counting kit assay. Real-time quantitative PCR and Western blot were used to detect the expression of inflammatory mediators. The endothelial barrier permeability was assessed by measuring permeability to FITC-labeled dextran. The distribution of occludin was detected by immunofluorescence. IL-22R1 mRNA expression was noted in HUVECs. IL-22 could enhance the proliferation ability of HUVECs and suppress lipopolysaccharide (LPS)-induced proliferation inhibition in these cells. IL-22 also enhanced the production of CCL2 and CCL20 by HUVECs. Besides, IL-22 could improve barrier function and decrease LPS-induced increased cellular permeability and inhibit the LPS-induced destruction of occludin in HUVECs. IL-22 may play a protective role in the development of vasculitis.

Entities:  

Keywords:  Behcet syndrome; IL-22; LPS; inflammatory; vasculitis

Mesh:

Substances:

Year:  2016        PMID: 27059499     DOI: 10.1007/s10753-016-0341-3

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  36 in total

1.  Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes.

Authors:  S V Kotenko; L S Izotova; O V Mirochnitchenko; E Esterova; H Dickensheets; R P Donnelly; S Pestka
Journal:  J Biol Chem       Date:  2000-10-16       Impact factor: 5.157

2.  Ecklonia cava extracts inhibit lipopolysaccharide induced inflammatory responses in human endothelial cells.

Authors:  Tae Hoon Kim; Jong-Sup Bae
Journal:  Food Chem Toxicol       Date:  2010-04-02       Impact factor: 6.023

3.  ZO-1 and -2 Are Required for TRPV1-Modulated Paracellular Permeability.

Authors:  J Li; X Cong; Y Zhang; R L Xiang; M Mei; N Y Yang; Y C Su; S Choi; K Park; L W Zhang; L L Wu; G Y Yu
Journal:  J Dent Res       Date:  2015-10-13       Impact factor: 6.116

4.  Synergistic protective effects of escin and low‑dose glucocorticoids against vascular endothelial growth factor‑induced blood‑retinal barrier breakdown in retinal pigment epithelial and umbilical vein endothelial cells.

Authors:  Fenglan Zhang; Xuejing Man; Huajun Yu; Limei Liu; Yuanbin Li
Journal:  Mol Med Rep       Date:  2014-10-31       Impact factor: 2.952

5.  Genomic structure and inducible expression of the IL-22 receptor alpha chain in mice.

Authors:  A Tachiiri; R Imamura; Y Wang; M Fukui; M Umemura; T Suda
Journal:  Genes Immun       Date:  2003-03       Impact factor: 2.676

Review 6.  IL-22 in tissue-protective therapy.

Authors:  Heiko Mühl; Patrick Scheiermann; Malte Bachmann; Lorena Härdle; Anika Heinrichs; Josef Pfeilschifter
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

7.  Application of interleukin-22 mediates protection in experimental acetaminophen-induced acute liver injury.

Authors:  Patrick Scheiermann; Malte Bachmann; Itamar Goren; Bernhard Zwissler; Josef Pfeilschifter; Heiko Mühl
Journal:  Am J Pathol       Date:  2013-01-30       Impact factor: 4.307

8.  Curcumin inhibits proliferation of interleukin-22-treated HaCaT cells.

Authors:  Yi Zhao; Jun Sun; Wei Dou; Jin-Hong Hu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

9.  IL-22 increases the innate immunity of tissues.

Authors:  Kerstin Wolk; Stefanie Kunz; Ellen Witte; Markus Friedrich; Khusru Asadullah; Robert Sabat
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

10.  Bixa orellana leaf extract suppresses histamine-induced endothelial hyperpermeability via the PLC-NO-cGMP signaling cascade.

Authors:  Yoke Keong Yong; Hoe Siong Chiong; Muhd Nazrul Somchit; Zuraini Ahmad
Journal:  BMC Complement Altern Med       Date:  2015-10-14       Impact factor: 3.659

View more
  2 in total

1.  Interleukin-22 Immunotherapy during Severe Influenza Enhances Lung Tissue Integrity and Reduces Secondary Bacterial Systemic Invasion.

Authors:  Ronan Le Goffic; François Trottein; Adeline Barthelemy; Valentin Sencio; Daphnée Soulard; Lucie Deruyter; Christelle Faveeuw
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

Review 2.  Respiratory Barrier as a Safeguard and Regulator of Defense Against Influenza A Virus and Streptococcus pneumoniae.

Authors:  Kim S LeMessurier; Meenakshi Tiwary; Nicholas P Morin; Amali E Samarasinghe
Journal:  Front Immunol       Date:  2020-02-04       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.